Germinoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
Simrat Sarai (talk | contribs) No edit summary |
Mahshid |
||
Line 18: | Line 18: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] |
Latest revision as of 23:35, 26 November 2017
Germinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Germinoma other imaging findings On the Web |
American Roentgen Ray Society Images of Germinoma other imaging findings |
Risk calculators and risk factors for Germinoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Other diagnostic studies for germinoma include PET scan.[1]
Other Imaging Findings
Studies have reported that 18F-fluorodeoxyglucose PET(FDG-PET) was able to detect the presence of germinomas while 11C-methionine PET (MET-PET) can help define tumor contour to plan for biopsy or surgery.[1]
References
- ↑ 1.0 1.1 Okochi Y, Nihashi T, Fujii M, Kato K, Okada Y, Ando Y; et al. (2014). "Clinical use of (11)C-methionine and (18)F-FDG-PET for germinoma in central nervous system". Ann Nucl Med. 28 (2): 94–102. doi:10.1007/s12149-013-0787-4. PMC 3926980. PMID 24272066.